Biodesix

Earnings Roundup: OraSure Technologies, Opko Health, Biodesix, Sophia Genetics,

OraSure, Opko, Sophia Genetics, and Biodesix reported their third quarter financial results this week.

In Brief This Week: Labcorp; T2 Biosystem; MiRxes; Accelerate Diagnostics; and More

News items for the week of Aug. 7, 2023.

In Brief This Week: Thermo Fisher Scientific, Danaher, Accelerate Diagnostics, Oncocyte, More

News items for the week of May 8, 2023.

In Brief This Week: MDxHealth, Biodesix, FIND, Alverno Labs, Ibex Medical Analytics

News items for the week of March 6, 2023.

In Brief This Week: NIH, Thermo Fisher Scientific, Biocept, Castle Biosciences, Biodesix

News items for the week of Nov. 21, 2022.

Nov 21, 2022

Biodesix to Sell $35.1M in Common Stock, Inks $50M Loan Agreement

Oct 17, 2022

Biodesix Nabs US Federal Supply Schedule Contract for Lung Cancer Tests

Aug 5, 2022

Earnings Roundup: Chembio Diagnostics, Exagen, Opko Health, Biodesix

Jun 30, 2022

Philips Incorporating Biodesix Nodify Test Into Lung Cancer Patient Management System

Jun 3, 2022

Biodesix, Memorial Sloan Kettering Team on Minimal Residual Disease Test

May 11, 2022

Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results

Apr 11, 2022

Biodesix Raises $11.7M in Private Placement, Amends Loan Agreement

Mar 14, 2022

Biodesix Q4 Revenues Decline 73 Percent on Drop in COVID-19 Testing

Mar 8, 2022

Biodesix Inks $50M Stock Sale Agreement

Jan 5, 2022

Biodesix Raises Approximately $16.3M in Sale of Common Shares, Amends $30M Term Loan

Dec 1, 2021

Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests

Nov 15, 2021

Biodesix Q3 Revenues Down 29 Percent on Lower COVID-19 Test Sales but Tops Estimates

Oct 27, 2021

Biodesix Aims to Makes its AI-Driven Diagnostic Algorithms More Transparent for Physicians
Premium

Aug 10, 2021

Biodesix Q2 Revenues Shoot up but Fall Short of Wall Street Expectations

May 11, 2021

Biodesix Q1 Revenues Soar on COVID-19 Testing

Apr 19, 2021

Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market
Premium

Mar 24, 2021

Biodesix Secures $30M Term Loan

Mar 16, 2021

Biodesix Q4 Revenues More Than Triple on COVID-19 Testing

Mar 12, 2021

Biodesix

Earnings Roundup: OraSure Technologies, Opko Health, Biodesix, Sophia Genetics,

In Brief This Week: Labcorp; T2 Biosystem; MiRxes; Accelerate Diagnostics; and More

In Brief This Week: Thermo Fisher Scientific, Danaher, Accelerate Diagnostics, Oncocyte, More

In Brief This Week: MDxHealth, Biodesix, FIND, Alverno Labs, Ibex Medical Analytics

In Brief This Week: NIH, Thermo Fisher Scientific, Biocept, Castle Biosciences, Biodesix

Top Five Articles on 360Dx Last Week: Siemens Healthineers Dx Changes; Job Cuts at Sema4; and More

Biodesix to Sell $35.1M in Common Stock, Inks $50M Loan Agreement

Biodesix Nabs US Federal Supply Schedule Contract for Lung Cancer Tests

Earnings Roundup: Chembio Diagnostics, Exagen, Opko Health, Biodesix

Philips Incorporating Biodesix Nodify Test Into Lung Cancer Patient Management System

Biodesix, Memorial Sloan Kettering Team on Minimal Residual Disease Test

Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results

Biodesix Raises $11.7M in Private Placement, Amends Loan Agreement

Biodesix Q4 Revenues Decline 73 Percent on Drop in COVID-19 Testing

Biodesix Inks $50M Stock Sale Agreement

Biodesix Raises Approximately $16.3M in Sale of Common Shares, Amends $30M Term Loan

Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests

Biodesix Q3 Revenues Down 29 Percent on Lower COVID-19 Test Sales but Tops Estimates

Biodesix Aims to Makes its AI-Driven Diagnostic Algorithms More Transparent for Physicians
Premium

Biodesix Q2 Revenues Shoot up but Fall Short of Wall Street Expectations

Biodesix Q1 Revenues Soar on COVID-19 Testing

Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market
Premium

Biodesix Secures $30M Term Loan

Biodesix Q4 Revenues More Than Triple on COVID-19 Testing

COVID-19 Pandemic Changing Digital Innovations, Care Models for Lab Industry, Panelists Say at ACLA
Premium

Sera Prognostic Shares Spike on Promising Interim Results in Study for Preterm Birth Test

Ovarian Cancer Detected Early With DNA From Pap Smear in Proof-of-Principle Study

Durin Technologies Closes $3.5M Funding Round

Texas Physicians, Hospital Executive Pay $880K to Resolve Federal Lab Fraud Allegations

DiaCarta OTC Fecal Occult Blood Test Receives FDA Clearance

First Light Diagnostics Gets FDA Clearance for Anthrax Toxin Test

Biodesix

Biodesix Aims to Makes its AI-Driven Diagnostic Algorithms More Transparent for Physicians Premium

Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market Premium

COVID-19 Pandemic Changing Digital Innovations, Care Models for Lab Industry, Panelists Say at ACLA Premium

Biodesix Aims to Makes its AI-Driven Diagnostic Algorithms More Transparent for Physicians
Premium

Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market
Premium

COVID-19 Pandemic Changing Digital Innovations, Care Models for Lab Industry, Panelists Say at ACLA
Premium